Can I have sex if I have a yeast infection?

Vulvovaginal candidiasis (commonly called a vaginal yeast infection) is a frequent condition affecting people with vaginas. It is caused most often by Candida albicans, a yeast that normally lives in small amounts on mucous membranes and skin. When conditions change in a way that favors fungal overgrowth, symptomatic infection can result. Because symptoms are local and commonly include itching, irritation and pain, many patients ask whether sexual activity is safe during an active infection. This article reviews the clinical features, diagnosis and treatment of vulvovaginal candidiasis and provides evidence‑based guidance about sexual activity, partner management and prevention. Information and recommendations are drawn from clinical guidance and patient education materials from professional and public health organizations (ACOG, NIH/MedlinePlus, Mayo Clinic, Cleveland Clinic).

What is vulvovaginal candidiasis?

Vulvovaginal candidiasis (VVC) is an inflammatory condition of the vulva and vagina caused by Candida species. Candida organisms are part of the normal genital flora in many healthy women; disease occurs when fungal proliferation exceeds the host’s local defenses. Symptoms typically include vulvar and vaginal itching, burning, dyspareunia (discomfort with sexual activity), vulvar erythema and a thick, white, cottage‑cheese–like vaginal discharge in many—but not all—cases (Mayo Clinic; Cleveland Clinic). Unlike bacterial vaginosis or many sexually transmitted infections, VVC is not primarily characterized by a foul odor.

VVC can be classified as:

Uncomplicated: Infrequent episodes, mild to moderate symptoms, Candida albicans susceptible to standard therapies, and no immunocompromise or pregnancy.
Complicated (recurrent or severe): Frequent episodes (four or more per year), severe symptoms, non‑albicans species, pregnancy, or immunosuppression (NIH/MedlinePlus; ACOG).

Common signs and symptoms

Typical symptoms and clinical signs include:

Intense vulvar and vaginal itching or soreness
Vaginal irritation and burning (worse with urination or sexual activity)
Thick, white, curdy vaginal discharge
Vulvar erythema, swelling or fissuring
Dysuria (superficial burning on urination) in some cases

The intensity of symptoms varies. Some patients have only mild pruritus, whereas others experience painful inflammation that interferes with daily activities and sexual function (Mayo Clinic; Cleveland Clinic).

Causes and risk factors

Several factors promote Candida overgrowth by altering the local vaginal environment or reducing host defenses:

Recent or prolonged antibiotic use (disturbs normal bacterial flora)
Pregnancy and hormonal fluctuations (estrogen increases glycogen in vaginal cells)
Uncontrolled diabetes mellitus or high blood glucose
Systemic or local immunosuppression (e.g., corticosteroids, HIV)
Use of intrauterine devices or hormonal contraceptives in some individuals
Tight, non‑breathable clothing and lasting moisture (creates a humid environment)
Sexual activity can be a coincident factor but is not the primary cause (ACOG; NIH/MedlinePlus)

Although Candida is not classified in the same manner as many sexually transmitted infections, sexual activity can transmit yeast between partners; however, routine partner treatment is not generally recommended unless the partner is symptomatic (Cleveland Clinic; ACOG).

How is a yeast infection diagnosed?

Diagnosis usually begins with a history and pelvic examination. Clinicians look for characteristic clinical signs and may obtain vaginal secretions for testing:

Wet mount microscopy with saline or potassium hydroxide (KOH) preparation to look for yeast forms or pseudohyphae
Vaginal culture, particularly for recurrent or treatment‑resistant infections, to identify non‑albicans species
Point‑of‑care tests or laboratory testing to exclude other causes (bacterial vaginosis, trichomoniasis) or sexually transmitted infections if symptoms or history suggest them (ACOG; Mayo Clinic)

Self‑diagnosis and empirical treatment with over‑the‑counter medications are common, but if symptoms are atypical, recurrent, severe, or not improved by standard therapy, clinicians recommend evaluation and possible culture.

Treatment options

Management depends on severity, pregnancy status and whether the episode is uncomplicated or recurrent.

Topical azole antifungals (intravaginal)

Over‑the‑counter intravaginal azoles (miconazole, clotrimazole) are effective for uncomplicated VVC and are available as single‑dose suppositories or multi‑day creams (Mayo Clinic; Cleveland Clinic).
Topical therapy is considered safe and effective for nonpregnant patients and is preferred during pregnancy over systemic therapy.

Oral azole (fluconazole)

A single 150 mg oral dose of fluconazole is a commonly used prescription option for uncomplicated VVC in nonpregnant patients (Mayo Clinic). For some patients with recurrent or severe disease, multiple oral doses or a maintenance regimen may be required.
Fluconazole is usually avoided during pregnancy due to associations with teratogenicity at repeated high doses; topical azoles are preferred (ACOG).

Treatment for recurrent vulvovaginal candidiasis (rVVC)

rVVC (≥4 episodes per year) requires different management: an initial induction course followed by a weekly or twice‑weekly maintenance regimen for months, and sometimes evaluation for underlying conditions such as diabetes or immune dysfunction (NIH/MedlinePlus; ACOG).
For non‑albicans species or refractory infections, boric acid vaginal suppositories and other nonstandard therapies may be used under clinician supervision because safety data are limited (Mayo Clinic).

Can I have sex if I have a yeast infection?

Clinical recommendations regarding sexual activity during an active vulvovaginal candidiasis episode are guided by three key considerations: symptom severity and comfort, the potential for transmission and reinfection, and the effect of treatments on barrier methods.

General guidance:

Avoid intercourse and other activities that cause friction or irritation while symptomatic. Active inflammation and tissue breakdown increase pain and can prolong healing; sexual activity frequently exacerbates symptoms and delays recovery (Cleveland Clinic; Mayo Clinic).
Avoid sexual activity until symptoms have resolved and treatment is complete. This reduces the risk of discomfort and decreases the chance of transmitting yeast to a partner or of being re‑infected after treatment.

Rationale:

Discomfort and pain: The vulvar tissue is often inflamed and sensitive; friction during intercourse causes additional irritation and may aggravate symptoms.
Transmission and reinfection: Although Candida is not primarily an STI, it can be transferred between partners. Male partners may develop balanitis (inflammation of the penile skin), and female partners may develop symptomatic infection after unprotected sexual contact. Many partners remain asymptomatic, and routine partner treatment is not indicated unless the partner has symptoms (ACOG; Cleveland Clinic).
Treatment interactions with condoms: Some intravaginal treatments (creams, oils) can degrade latex condoms or diaphragms and reduce their effectiveness. If topical intravaginal products are used and sex is resumed, consider using latex‑safe alternatives (e.g., polyurethane condoms) or abstaining until treatment is finished and lubricants or creams are no longer present (Mayo Clinic).

Short answer: It is medically advisable to refrain from penetrative intercourse or other activities that cause friction until symptoms have substantially improved and any prescribed treatment course is completed.

What about kissing or other non‑penetrative activities?

Non‑penetrative sexual activities such as kissing are unlikely to worsen vulvovaginal candidiasis in the individual with symptoms. However, certain activities that provide direct fungal exposure to oral mucosa (e.g., oral‑genital contact) can transmit Candida and, in rare cases, cause oral candidiasis (thrush) or genital infection in the partner. If either partner has symptoms of oral candidiasis (white patches, sore throat), or genital symptoms, it is prudent to avoid activities that may transmit the organism until both have been evaluated and treated as appropriate (Cleveland Clinic).

Should my partner be treated?

Routine treatment of sexual partners is not recommended when the patient has uncomplicated VVC and the partner is asymptomatic. Exceptions include:

Symptomatic partner: If a male or female partner develops symptoms (e.g., penile or vulvar irritation, rashes, or discharge), evaluation and treatment are indicated.
Recurrent or refractory infections: In selected cases of recurrent vulvovaginal candidiasis where reinfection is suspected, simultaneous partner evaluation and treatment may be considered after clinician evaluation (ACOG; Cleveland Clinic).

Men may develop candidal balanitis with symptoms such as redness, itching or irritation of the glans or foreskin. In such cases, topical antifungal agents are typically effective.

Do condoms prevent transmission?

Condoms provide a barrier that reduces the chance of transmitting many genital infections. For Candida, condoms may reduce direct skin‑to‑skin or mucosal contact and therefore may lower transmission risk. However, condoms are not fully protective against organisms that can inhabit external genital skin. Additionally, intravaginal creams and oils used to treat VVC can weaken latex condoms, potentially reducing their effectiveness until the cream is fully cleared from the vagina. For this reason, it is preferable to avoid intercourse during active infection and treatment. If sex occurs, consider using a non‑latex condom and ensure that intravaginal treatments have been rinsed or cleared (Mayo Clinic).

Special considerations: pregnancy

Vulvovaginal candidiasis is common during pregnancy. Management considerations:

Topical azole therapy (intravaginal clotrimazole or miconazole) is preferred during pregnancy because systemic azoles, such as oral fluconazole, are avoided particularly in the first trimester and when repeated dosing is contemplated (ACOG; NIH/MedlinePlus).
Sexual activity during pregnancy with an active yeast infection should generally be avoided until therapy is completed and symptoms have resolved to reduce discomfort and potential partner transmission.
Pregnant patients with persistent or recurrent symptoms should be evaluated by their clinician for appropriate therapy and testing.

Recurrent vulvovaginal candidiasis: what to do

Recurrent VVC is defined as four or more episodes in 12 months. Management includes:

Confirming the diagnosis with culture to identify Candida species; non‑albicans species (e.g., Candida glabrata) are more likely to be resistant to azoles and may require alternative or longer therapies.
Initial induction treatment to resolve the acute episode followed by a maintenance regimen (often weekly oral fluconazole for six months in nonpregnant patients) for rVVC due to Candida albicans (NIH/MedlinePlus; ACOG).
Evaluation for predisposing conditions: uncontrolled diabetes, immunosuppressive therapy, HIV, or changes in personal hygiene or sexual practices that might increase recurrence.
Avoiding unproven or potentially harmful self‑treatments; consult a clinician about options such as boric acid suppositories for non‑albicans recurrent cases, which are used off‑label and require clinician guidance for safe use (Mayo Clinic).

Preventive measures

Several reasonably simple measures reduce the risk of symptomatic candidiasis:

Avoid unnecessary antibiotics and discuss alternatives or prophylaxis only when clinically indicated.
Maintain good vulvar hygiene: gentle cleansing, avoidance of douching, and using mild, unscented products.
Wear breathable cotton underwear and loose‑fitting clothing to reduce moisture and heat in the genital area.
Control blood glucose effectively if diabetic.
After treatment and symptom resolution, avoid prolonged moisture and personal products that can alter local flora (scented feminine products) (Cleveland Clinic; NIH/MedlinePlus).

The evidence supporting probiotics for prevention is mixed; some studies suggest benefit from specific strains, but routine recommendation is not universally endorsed. Discuss the option with a clinician.

When to seek medical care

Seek clinician evaluation if:

Symptoms are severe (marked pain, significant swelling, bleeding) or do not improve with appropriate over‑the‑counter treatment.
Symptoms recur frequently (≥4 episodes per year).
You are pregnant and have symptoms suggestive of yeast infection.
There is uncertainty about the cause of symptoms (other conditions such as bacterial vaginosis, trichomoniasis, or STIs can cause similar complaints).
You or your partner have new or worsening symptoms after attempted treatment.

Laboratory testing (microscopy, culture) may be necessary to confirm the diagnosis and guide treatment, particularly for atypical or recurrent infections (ACOG; Mayo Clinic).

Frequently asked clinical questions

Is a yeast infection an STI?

No. Vulvovaginal candidiasis is not classified as a sexually transmitted infection, although sexual contact can transmit Candida between partners. Routine partner treatment is not recommended unless the partner is symptomatic (Cleveland Clinic; ACOG).

Can I get pregnant if I have a yeast infection?

Yes. VVC does not prevent conception. However, if you are pregnant and symptomatic, consult your clinician for pregnancy‑appropriate therapy.

Does treatment affect contraception?

Intravaginal creams and oils can weaken latex condoms and diaphragms. If you are using intravaginal topical therapy, avoid intercourse or use non‑latex barriers until treatment residue is gone (Mayo Clinic).

Can oral antifungals (fluconazole) be used during pregnancy?

Systemic fluconazole is generally avoided in pregnancy, particularly in the first trimester, and topical azoles are preferred. Clinical decisions depend on individual circumstances and should be made with obstetric guidance (ACOG).

Practical advice for couples

Communication: Inform your partner about your diagnosis and intended treatment plan. Discuss avoidance of sexual activity until symptoms improve.
Hygiene: Both partners should practice good genital hygiene. If a partner develops symptoms, seek medical evaluation.
Treatment adherence: Complete the prescribed course of therapy even if symptoms begin to improve, and follow up with your clinician if symptoms persist.
Condom use: If you decide to resume sexual activity before treatment is complete, use non‑latex condoms and be aware that intravaginal medications may interfere with barrier effectiveness. Preferably, wait until treatment is finished and symptoms have resolved.

Summary and clinical takeaways

Vulvovaginal candidiasis is a common condition caused by Candida species and often produces itching, irritation and abnormal discharge.
Diagnosis is clinical but may be supported by microscopy and culture, particularly in recurrent or atypical cases.
Treatment options include topical intravaginal azoles and oral fluconazole; therapy selection is influenced by pregnancy status and whether the infection is recurrent or caused by non‑albicans species (Mayo Clinic; Cleveland Clinic; ACOG).
Sexual intercourse is not recommended while symptomatic and during active treatment because friction can increase pain and inflammation, and sexual contact can lead to partner symptoms or reinfection.
Routine partner treatment is not indicated unless the partner is symptomatic.
Preventive strategies and evaluation for contributing medical conditions (e.g., diabetes) help reduce recurrence.
Seek medical care for severe, recurrent, or treatment‑resistant symptoms, or if you are pregnant.

For reliable, up‑to‑date patient education and clinical guidance, consult resources from the American College of Obstetricians and Gynecologists (ACOG), the National Institutes of Health/MedlinePlus, the Mayo Clinic and the Cleveland Clinic.

References

American College of Obstetricians and Gynecologists (ACOG). Patient FAQs: Vaginal Yeast Infections. https://www.acog.org/womens-health/faqs/vaginal-yeast-infections
National Institutes of Health (NIH) / MedlinePlus. Vaginal Yeast Infections. https://medlineplus.gov/yeastinfections.html
Mayo Clinic. Vaginal Yeast Infection (Vulvovaginal Candidiasis). https://www.mayoclinic.org/diseases-conditions/vaginal-yeast-infection
Cleveland Clinic. Vaginal Yeast Infection. https://my.clevelandclinic.org/health/diseases/22047-vaginal-yeast-infection

(These references provide general patient education and clinical guidance; individual care decisions should be made in consultation with a licensed healthcare professional.)